TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: An overview

Journal of Neuroimmunology

Volumn 72, Issue 2, 1997, Pages 163-168

  Klinkert, W E F ^a   Kojima, K ^a   Lesslauer, W ^b   Rinner, W ^c   Lassmann, H ^c   Wekerle, H ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

animal models; experimental allergic encephalomyelitis; multiple sclerosis; therapy; TNF receptors

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G1; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DEMYELINATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED LEW; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 0031040849     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00183-X     Document Type: Conference Paper

References (44)

1. Achiron, A., Margalit, R., Hershkovitz, R., Markovits, D., Reshef, T., Melamed, E., Cohen, I.R. and Lider, O. (1994) Intravenous immunoglobulin treatment of experimental T-cell-mediated auto-immune disease. Upregulation of T-cell proliferation and downregulation of tumor necrosis factor a secretion. J. Clin. Invest. 93, 600-605.
2. Aggarwal, B.B. and Natarajan, K. (1996) Tumor necrosis factor: Developments during the last decade. Eur. Cytokine Netw. 7, 93-124.
3. + T-cells independent of tumor necrosis factor. Ann. Neurol. 35, 341-348.
4. Ashkenazi, A., Marsters, S.A., Capon, D.J., Chamow, S.M., Figari, I.S., Pennica, P., Goeddel, D.V., Palladino, M.A. and Smith, D.H. (1991) Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. U.S.A. 88, 10535-10539.
5. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF-receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
6. Balasingam, V., Tejada-Berges, T., Wright, E., Bouckova, R. and Yong, V.W. (1994) Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14, 846-456.
7. Barbara, J.A.J., Smith, W.B., Gamble, J.R., Van Ostade, X., Vandenabeele, P., Tavernier, J., Fiers, W., Vadas, M.A. and Lopez, A.F. (1994) Dissociation of TNF-α cytotoxic and pro-inflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO 13, 843-850.
8. Barna, B., Estes, M., Jacobs, B.S., Hudson, S. and Ransohoff, R.M. (1990) Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 30, 239-243.
9. Brockhaus, M., Schoenfeld, H.-J., Schlaeger, E.-J., Hunzicher, E.J., Lesslauer, W. and Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 3127-3131.
10. Brosnan, C.S., Selmaj, K. and Raine, C.S. (1988) Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18, 87-94.
11. Doherty, G.M., Lange, J.R., Langstein, H.N., Alexander, H.R., Buresh, C.M. and Norton, J.A. (1992) Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149, 1666-1670.
12. Erickson, S.L., De Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheenan, K.C.F., Schreiber, R.D., Goeddel, D.V. and Moore, M.W. (1994) Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-deficient mice. Nature 372, 560-563.
13. Haak-Frendscho, M., Marsters, S.A., Mordenti, J., Brady, S., Gillett, N.A., Chen, S.A. and Ashkenazi, A. (1994) Inhibition of TNF by a TNF-receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody J. Immunol. 152, 1347-1353.
14. Hershkoviz, R., Mor, F., Gilat, D., Cohen, I.R. and Lider, O. (1992) T-cells in the spinal cord in experimental auto-immune encephalomyelitis are matrix adherent and secrete tumor necrosis factor alpha. J. Neuroimmunol. 37, 161-166.
15. Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
16. Huitinga, I., Van Rooijen, N., De Groot, C.J.A., Uitdehaag, B.M.J. and Dijkstra, C.D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033.
17. Kim, K.S., Wass, C.A., Cross, A.S. and Opal, S.M. (1992) Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 11, 293-298.
18. Kojima, K., Berger, T., Lassmann, H., Hinze-Seich, D., Zhang, Y., Gehrmann, J., Wekerle, H. and Linington, C. (1994) Experimental auto-immune panencephalitis and uveoretinitis in the Lewis rat transferred by T-lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180, 817-829.
19. Kuroda, Y. and Shimamoto, Y. (1991) Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34, 159-164.
20. Körner, H., Goodsall, A.L., Lemckert, F.A., Scallon, B.J., Ghrayeb, J., Ford, A.L. and Sedgwick, J.D. (1995) Unimpaired autoreactive T-cell traffic within the central-nervous-system during tumor-necrosis-factor receptor-mediated inhibition of experimental auto-immune encephalomyelitis. Proc. Natl. Acad. Sci. USA 92, 11066-11070.
21. Lachman, L.B., Brown, D.C. and Dinarello, C.A. (1987) Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. J. Immunol. 138, 2913-2916.
22. Lassmann, H. (1983) Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis. Springer Verlag, Berlin.
23. Lesslauer, W., Tabuchi, H., Gentz, R., Brockhaus, M., Schlaeger, E.-J., Grau, G., Piguet, P.-F., Pointaire, P., Vassalli, P. and Loetscher, H.-R. (1991) Recombinant soluble TNF receptor proteins protect mice from LPS-induced lethality. Eur. J. Immunol. 21, 2883-2886.
24. Loetscher, H.R., Augehru, P., Schlaeger, E.J., Gentz, R. and Lesslauer, W. (1993) Efficacy of a chimeric TNFR-IgG fusion protein to inhibit TNF activity in animal models of septic shock. In: J. Levine et al. (Eds.), Endotoxin Research, Vol. 2., Bacterial Endotoxin: Recognition and Effector Mechanisms. Int. Congr. Ser. No. 1020. Elsevier, New York, pp. 455-462.
25. Martin, D., Near, S.L., Bendele, A. and Russell, D.A. (1995) Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 131, 221-228.
26. Massa, P.T., Schimpl, A., Wecker, E. and Ter Meulen, V. (1987a) Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc. Natl. Acad. Sci. USA 84, 7242-7245.
27. Massa, P.T., Ter Meulen, V. and Fontana, A. (1987b) Hyperinducibility of Ia antigen on astrocytes correlated with strain-specific susceptibility to experimental auto-immune encephalomyelitis. Proc. Natl. Acad. Sci. USA 84, 4219-4223.
28. Riethmüller, G., Rieber, E.P., Kiefersauer, S., Prinz, J., Van der Lubbe, P., Breedveld, F., Eisenburg, J., Krüger, K., Deusch, K., Sanders, M. and Reiter, C. (1992) From antilymphocyte serum to therapeutic monoclonal antibodies: First experiences with a chimeric CD4 antibody in the treatment of auto-immune disease. Immunol. Rev. 129, 81-103.
29. Rothe, J., Lesslauer, W., Lötscher, H., Lang, Y., Koebel, P., Köntgen, F., Althage, A., Zinkernagel, R.M., Steinmetz, M. and Bluethmann, H. (1993) Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
30. Rott, O., Cash, E. and Fleischer, B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type-1, but not type-2 associated lymphokine production, prevents induction of experimental auto-immune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23, 1745-1751.
31. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. and Clark, R.B. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-11200.
32. Schlüsener, H.J., Sobel, R.A., Linington, C. and Weiner, H.L. (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016-4021.
33. Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T. (1995) Prevention of chronic relapsing experimental auto-immune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56, 153-141.
34. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991a) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
35. Selmaj, K., Raine, C.S. and Cross, A.M. (1991b) Anti-tumor necrosis factor therapy abrogates auto-immune demyelination. Ann. Neurol. 30, 694-700.
36. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
37. Shalaby, M.R., Sundan, A., Loetscher, H., Brockhaus, M., Lesslauer, W. and Espevik, T. (1990) Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 172, 1517-1520.
38. Sharief, M.K., Phil, M. and Hentges, R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 7, 467-472.
39. Sinha, B., Semmler, J., Eisenhut, T., Eigler, A. and Endres, S. (1995) Enhanced tumor necrosis factor suppression and cyclic monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25, 147-153.
40. Sommer, N., Löschmann, P.-A., Northoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., Dichgans, J. and Martin, R. (1995) The anti-depressant rolipram suppresses cytokine production and prevents auto-immune encephalomyelitis. Nature Med. 1, 244-248.
41. Stein, M. and Gordon, S. (1991) Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: Role of cell stimulation and specific phagocytic plasma membrane receptors. Eur. J. Immunol. 21, 431-437.
42. Tartaglia, L.A., Weber, R.F., Figari, I.S., Reynolds, C., Palladino, M.A. and Goedell, M.V. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9296.
43. Vass, K., Heininger, K., Schäfer, B., Linington, C. and Lassmann, H. (1992) Interferon-γ potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 32, 198-206.
44. Woodroofe, M.N. and Cuzner, M.L. (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization. Cytokine 5, 583-588.